Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...

ELV001 aiming to disrupt the treatment paradigm for patients with incomplete response to standard of care (methotrexate + TNF inhibitors)Phase 2b trial enrolling approximately 180 patients across nine ...

RA can affect your lifespan in various ways related to cardiovascular disease, lung disease, infection, depression, and ...

Despite slightly worse functional outcomes compared with patients on private insurance, patients undergoing total knee arthroplasty who were on Medicaid had high patient satisfactions scores, ...

Therapeutic drug monitoring would seem like an obvious match with rheumatology. Patients with clinically challenging ...

Background Adalimumab is an effective first-line biologic therapy used to treat children and young people (CYP) with juvenile idiopathic arthritis (JIA) and non-infectious uveitis (NIU). However, the ...

ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill Approval supported by four phase 3 studies that met ...

I used to be that annoying person who prided myself on never going to the doctor, who relished my apparent immunity to ...

The new guidelines aim to give doctors and their patients an individualized and clear path to follow. Heart disease remains the leading cause of death worldwide, according to the ...

Johnson & Johnson introduces the first and only IL-23R targeted oral peptide that delivers complete skin clearance and favorable safety profile in a once-daily pill ICOTYDE ...

Recruitment for the rheumatoid arthritis (RA) sub-study of the SKYWAY basket trial is complete; Week 12 topline data now expected in Q3 ...